Burrage Capital Management’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Burrage Capital Management’s Portfolio GTHX Stock Details GTHX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-47,708	Closed	-$1.05M	–	20
2021 Q2	$1.05M	Sell	47,708 -70,000	-59%	-$1.55M	1.05%	21
2021 Q1	$2.83M	Hold	117,708	–	–	2.29%	23
2020 Q4	$2.12M	Sell	117,708 -110,889	-49%	-$1.66M	1.61%	22
2020 Q3	$2.64M	Sell	228,597 -145,279	-39%	-$2.4M	2.08%	18
2020 Q2	$9.07M	Sell	373,876 -4,269	-1%	-$70.6K	6.35%	4
2020 Q1	$3.9M	Sell	378,145 -36,263	-9%	-$677K	3.83%	10
2019 Q4	$11M	Buy	+414,408	New	+$9.69M	7.34%	4

Other funds holding GTHX

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

LOAMS

Lombard Odier Asset Management (Switzerland) Petit-Lancy, Switzerland $2.63B AUM 31.52% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Burrage Capital Management's GTHX Position: Q3 2021 in Review

Burrage Capital Management sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q3 2021, closing a stake of 47,708 shares — an estimated $1.05M sold.

Burrage Capital Management first reported a position in GTHX in Q4 2019 and held it in 7 quarters. The position peaked at $11M in Q4 2019. 115 funds tracked by Wall St. Rank hold GTHX as of Q3 2021.

Burrage Capital Management reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
Burrage Capital Management sold 47,708 G1 Therapeutics, Inc. Common Stock shares in Q3 2021, an estimated $1.05M.
Burrage Capital Management first reported a position in G1 Therapeutics, Inc. Common Stock in Q4 2019 and held it in 7 quarters.
Burrage Capital Management's G1 Therapeutics, Inc. Common Stock position peaked at $11M in Q4 2019.
115 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q3 2021.

Based on Burrage Capital Management's 13F filing for Q3 2021.